- NSE
- ZYDUSLIFE
- BSE
- 532321
- ISIN
- INE010B01027
ZYDUS LIFESCIENCES
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,215.90
+₹18.00 (+1.50%)
NSE close ·
ZYDUS LIFESCIENCES closed at ₹1,215.90 on 9 Nov 2026, up 1.50% on the day, and is up 28.79% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹860.60 to ₹1,245.50.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,21,286 Cr
- P/E (TTM)
- 29.2
- Industry P/E
- 35.5
- EPS (TTM)
- ₹41.64
- P/B
- 4.36
- Book value
- ₹278.87
- ROE
- 15.0%
- ROCE
- 15.0%
- Debt/equity
- 0.48
- Operating margin
- 18.7%
- Net margin
- 13.8%
- Dividend yield
- 0.08%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +23.95% | +17.45% |
| Net profit | −14.87% | +13.53% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹8,040 Cr | ₹928 Cr | −25.10% | ₹9.28 |
| Jun 2026 | ₹8,123 Cr | ₹990 Cr | −34.90% | ₹9.35 |
| Mar 2026 | ₹7,721 Cr | ₹1,341 Cr | +7.82% | ₹12.65 |
| Dec 2025 | ₹6,976 Cr | ₹1,023 Cr | −0.32% | ₹10.36 |
| Sep 2025 | ₹6,232 Cr | ₹1,239 Cr | +34.60% | ₹12.51 |
| Jun 2025 | ₹6,729 Cr | ₹1,521 Cr | +2.60% | ₹14.58 |
| Mar 2025 | ₹6,609 Cr | ₹1,244 Cr | −0.19% | ₹11.64 |
| Dec 2024 | ₹5,327 Cr | ₹1,026 Cr | +29.92% | ₹10.17 |
Armor risk check
ZYDUS LIFESCIENCES moves about 1.6× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is ZYDUS LIFESCIENCES's share price today?
ZYDUS LIFESCIENCES (NSE: ZYDUSLIFE) closed at ₹1,215.90 on 9 Nov 2026, up 1.50% from the previous close of ₹1,197.90. It traded between ₹1,195.90 and ₹1,232.30 that day.
What are ZYDUS LIFESCIENCES's 52-week high and low?
Over the last 52 weeks ZYDUS LIFESCIENCES traded between ₹835.50 and ₹1,266.60, adjusted for splits and bonuses.
What are ZYDUS LIFESCIENCES's NSE symbol, BSE code and ISIN?
ZYDUS LIFESCIENCES has NSE symbol ZYDUSLIFE, BSE code 532321, ISIN INE010B01027.
How has ZYDUS LIFESCIENCES performed over 1, 3 and 5 years?
ZYDUS LIFESCIENCES's share price return: 1Y +28.79%, 3Y +25.68% a year, 5Y +19.53% a year. Dividends are not included.
Does ZYDUS LIFESCIENCES pay a dividend?
Yes. ZYDUS LIFESCIENCES's latest dividend went ex on 24 Jul 2026: Final · ₹1.00 per share. Dividends over the past year come to a yield of 0.08% at the latest close.
What is ZYDUS LIFESCIENCES's P/E ratio?
ZYDUS LIFESCIENCES's P/E ratio is 29.2: the ₹1,215.90 close on 9 Nov 2026 over trailing twelve-month EPS of ₹41.64 (consolidated, four quarters to 30 Sep 2026).
What is ZYDUS LIFESCIENCES's market cap?
ZYDUS LIFESCIENCES's market cap is ₹1,21,286 Cr at the close on 9 Nov 2026.
Which sector is ZYDUS LIFESCIENCES in?
ZYDUS LIFESCIENCES is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how ZYDUS LIFESCIENCES fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app